Cargando…
Plasma Progerin in Patients With Hutchinson-Gilford Progeria Syndrome: Immunoassay Development and Clinical Evaluation
Hutchinson-Gilford progeria syndrome (HGPS) is an ultrarare, fatal, premature aging disease caused by a toxic protein called progerin. Circulating progerin has not been previously detected, precluding research using readily available biological samples. This study aimed to develop a plasma progerin...
Autores principales: | Gordon, Leslie B., Norris, Wendy, Hamren, Sarah, Goodson, Robert, LeClair, Jessica, Massaro, Joseph, Lyass, Asya, D’Agostino, Ralph B., Tuminelli, Kelsey, Kieran, Mark W., Kleinman, Monica E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10237348/ https://www.ncbi.nlm.nih.gov/pubmed/36919608 http://dx.doi.org/10.1161/CIRCULATIONAHA.122.060002 |
Ejemplares similares
-
Sulforaphane enhances progerin clearance in Hutchinson–Gilford progeria fibroblasts
por: Gabriel, Diana, et al.
Publicado: (2015) -
Progerin reduces LAP2α-telomere association in Hutchinson-Gilford progeria
por: Chojnowski, Alexandre, et al.
Publicado: (2015) -
Quantification of Farnesylated Progerin in Hutchinson-Gilford Progeria Patient Cells by Mass Spectrometry
por: Camafeita, Emilio, et al.
Publicado: (2022) -
Heterochromatin loss as a determinant of progerin‐induced DNA damage in Hutchinson–Gilford Progeria
por: Chojnowski, Alexandre, et al.
Publicado: (2020) -
Impact of Progerin Expression on Adipogenesis in Hutchinson—Gilford Progeria Skin-Derived Precursor Cells
por: Najdi, Farah, et al.
Publicado: (2021)